Oral Proteins And Peptides Trends and Opportunities 2025-2034: A Comprehensive Guide to Growth Insights
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What Factors Are Driving the Anticipated Growth Rate of the Oral Proteins And Peptides Market Through 2034?
The market size for oral proteins and peptides has witnessed substantial growth lately. It is projected to expand from a value of $1.27 billion in 2024 to $1.56 billion in 2025, translating to a compound annual growth rate (CAGR) of 22.7%. Factors such as an upsurge in chronic diseases, heightened investment in biotechnology for the innovation of oral protein therapies, a rising preference among consumers for non-invasive treatments, the growing biopharmaceutical sector, and an increased emphasis on personalized medicine contribute to the impressive growth in the historic period.
The market for oral proteins and peptides is anticipated to experience a tremendous surge in the coming years, escalating to a market size of $3.49 billion by 2029 at a CAGR of 22.3%. The projected growth in this period can be associated with a rising interest in patient-specific medications, increasing geriatric population, escalated spending on healthcare, an augmented necessity for cancer diagnostics, and a growing inclination towards oral medication. Key trends projected for the forecast period include the creation of innovative oral peptides boasting improved stability and effectiveness, the use of artificial intelligence in discovering new oral drug formulations, advancements in medical treatments, progress in drug delivery technologies, and inventive oral insulin formulations.
What Market Dynamics Are Playing a Key Role in Accelerating the Growth of the Oral Proteins And Peptides Market?
The escalation of the biopharmaceutical sector is predicted to spur the expansion of the oral proteins and peptides market. This industry is a subsector of the larger pharmaceutical industry, specializing in the development, production, and marketing of biological-based drugs. The growth within the biopharmaceutical sector can be attributed to progress in biotechnology, a surge in demand for personalized medicine, the growing instances of chronic diseases, and an increase in research and development investment. Biopharmaceuticals utilizing oral proteins and peptides offer the possibility of non-invasive delivery of therapeutics, improving patient adherence and diminishing the necessity for injections, due to their ability to target specific diseases with increased stability and absorption in the digestive system. The European Federation of Pharmaceutical Industries and Associations (EFPIA) reported in June 2023, that the overall bio-pharmaceutical production in Europe reached up to $384,200 million (€340,000 million) in 2022, showing a rise of roughly 4.95% from $366,267 million (€323,950 million) in 2021. Consequently, the expanding biopharmaceutical sector is paving the way for the growth of the oral proteins and peptides market.
Explore Comprehensive Insights Into The Global Oral Proteins And Peptides Market With A Free Sample Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19629&type=smp
Who Are the Major Industry Leaders Accelerating Growth in the Oral Proteins And Peptides Market?
Major companies operating in the oral proteins and peptides market are Pfizer Inc., Johnson & Johnson Services Inc., Roche Holding AG, Merck & Co. Inc., AbbVie Inc., Sanofi S.A., AstraZeneca PLC, Novartis AG, GlaxoSmithKline PLC, Eli Lilly and Company, Amgen Inc., Novo Nordisk A/S, Ipsen S.A., Biocon Limited, Xeris Pharmaceuticals Inc., Adocia S.A., Zealand Pharma A/S, Diabetology Ltd., Oramed Pharmaceuticals Inc., Palatin Technologies Inc., Entera Bio Ltd.
Which Current Trends Are Having the Most Impact on the Oral Proteins And Peptides Market?
Major players in the oral proteins and peptides market are taking innovative strides, one of which is the development of Oral Semaglutide, a novel product geared towards promoting patient compliance and ease. A revolutionary medication, Oral semaglutide, is making substantial strides in the domain of oral proteins and peptides. It acts as a glucagon-like peptide-1 (GLP-1) receptor agonist, primarily injected for treating type-2 diabetes and recently used for combating obesity. In a landmark move in January 2022, India’s Novo Nordisk India rolled out the world’s inaugural oral semaglutide, signifying a monumental progression in diabetes therapy. Hitherto available only as an injectable, Semaglutide, a GLP-1 receptor analogue (GLP-1 RA), now provides a handier oral alternative for managing type 2 diabetes. This innovation not only remolds diabetes management but also lays the foundation for future advancements in oral insulin formulations, possibly leading to more effective and patient-centric treatment options.
Secure Your Global Oral Proteins And Peptides Market Report Now for Fast and Efficient Delivery!
https://www.thebusinessresearchcompany.com/report/oral-proteins-and-peptides-global-market-report
Which Segments Play a Crucial Role in the Expansion of the Oral Proteins And Peptides Market?
The oral proteins and peptidesmarket covered in this report is segmented –
1) By Drug Type: Linaclotide, Calcitonin, Insulin, Plecanatide, Octreotide
2) By Biological Target: Guanylate Cyclase-C (GC-C), Insulin Receptor, Oxalate, Other Biological Targets
3) By Mechanism Of Action: Receptor Stimulation, Substrate Degradation, Other Mechanisms Of Action
4) By Application: Gastrointestinal Disorders, Bone Disease, Neurological Disorders, Diabetes, Metabolic Disorders, Hormonal Disorder, Cancer
Subsegments:
1) By Linaclotide: Indications For Irritable Bowel Syndrome (IBS), Indications For Chronic Idiopathic Constipation (CIC)
2) By Calcitonin: Calcitonin-Salmon, Synthetic Calcitonin, Calcitonin for Osteoporosis Treatment
3) By Insulin: Rapid-Acting Insulin, Long-Acting Insulin, Combination Insulin Products, Oral Insulin Formulations
4) By Plecanatide: Indications For Chronic Idiopathic Constipation (CIC), Indications For Irritable Bowel Syndrome With Constipation (IBS-C)
5) By Octreotide: Long-Acting Octreotide Formulations, Short-Acting Octreotide Formulations, Indications For Acromegaly And Neuroendocrine Tumors
Which Regions Are Key Players in the Growth of the Oral Proteins And Peptides Market?
North America was the largest region in the oral proteins and peptides market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oral proteins and peptides market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
How Is the Definition of the Oral Proteins And Peptides Market Impacting Future Growth?
Oral Proteins and Peptides refer to therapeutic proteins and peptides administered orally, typically in pills, capsules, or other ingestible formats. These biologically active molecules are designed to treat various medical conditions by leveraging their specific actions within the body.
Browse Through More Similar Reports By The Business Research Company:
Behavioral and Mental Health Software Global Market Report 2024
Oral Biologics & Biosimilars Global Market Report 2024
Intraoral Cameras Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/intraoral-cameras-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
